
Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval
STOCKHOLM (Reuters) -Denmark’s Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European Medicines Agency for approval, with one in three trial participants achieving 25% or more weight loss. Novo …